## Malignant Potential of Fibroadenoma **Key Point:** Fibroadenomas are benign breast tumours with negligible risk of malignant transformation. The risk of in situ or invasive carcinoma arising within a fibroadenoma is extremely rare (<0.1%). ## Epidemiology & Natural History | Feature | Data | |---------|------| | Malignant transformation rate | <0.1% | | Spontaneous regression rate | 10–20% over 2–3 years | | Growth rate (if any) | Slow; <2 cm/year typical | | Age of onset | Peak 15–35 years | | Hormone responsiveness | Yes (may enlarge in pregnancy) | **High-Yield:** Fibroadenomas are NOT a risk factor for breast cancer. They do not increase overall breast cancer risk and do not warrant prophylactic excision or intensive surveillance. ## Reassurance & Counselling Points 1. **Benign diagnosis:** Confirmed by core needle biopsy — no further diagnostic workup needed. 2. **No malignant potential:** Transformation is exceptionally rare and not a clinical concern. 3. **Observation is safe:** Serial clinical examination and ultrasound at 6–12 months is standard care. 4. **No increased cancer risk:** Fibroadenomas do not elevate breast cancer risk above population baseline. 5. **Excision is optional:** Offered only for patient preference, cosmetic concern, or diagnostic uncertainty — NOT for cancer prevention. **Clinical Pearl:** Phyllodes tumours (a rare variant) have higher malignant potential, but these are larger (typically >4 cm), present in older women, and have different imaging/histology. Simple fibroadenomas do not progress to phyllodes. ## Why This Patient Should Be Reassured Multiple fibroadenomas (as in this case) are common and benign. The presence of bilateral lesions does not increase malignant risk or change management. She should be counselled that observation with clinical follow-up is safe and appropriate. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.